Sugi Predict

Sugi Predict / Compounds / SCHEMBL4760604

SCHEMBL4760604

SCHEMBL4760604

Nc1ccccc1Nc1ccncc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.69
▸ GAA P10253 5/20 0.69
▸ ALDH1A1 P00352 4/20 0.69
▸ KDM4E B2RXH2 3/20 0.69
▸ MEN1 O00255 2/20 0.69
▸ KMT2A Q03164 2/20 0.69
▸ LMNA P02545 1/20 0.69
▸ CYP1A2 P05177 1/20 0.69
▸ CYP2D6 P10635 1/20 0.69
▸ CYP2C9 P11712 1/20 0.69
▸ CYP2C19 P33261 1/20 0.69
▸ SMN1; SMN2 Q16637 2/20 0.64
▸ TP53 P04637 1/20 0.64
▸ APP P05067 1/20 0.64
▸ HPGD P15428 1/20 0.64
▸ ALOX15 P16050 1/20 0.64
▸ SNCA P37840 1/20 0.64
▸ BLM P54132 1/20 0.64
▸ HSD17B10 Q99714 1/20 0.64
▸ TDP1 Q9NUW8 2/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29414655 1.00 MAPT (0.69) MAPTGAAALDH1A1KDM4EMEN1
Hydrochloric Acid SCHEMBL6832727 0.98 MAPT (0.67) MAPTGAAALDH1A1KDM4EMEN1
Hydrochloric Acid SCHEMBL6832726 0.98 MAPT (0.67) MAPTGAAALDH1A1KDM4EMEN1
SCHEMBL29580695 0.84 MAPT (0.59) MAPTGAAALDH1A1KDM4EMEN1
SCHEMBL1712793 0.84 ADRA2A (0.57) MAPTGAAALDH1A1KDM4EMEN1
SCHEMBL4607773 0.84 MAPT (0.86) MAPTGAAALDH1A1KDM4EMEN1
SCHEMBL29388147 0.82 MAPT (1.00) MAPTGAAALDH1A1KDM4EMEN1
SCHEMBL217480 0.82 MAPT (1.00) MAPTGAAALDH1A1KDM4EMEN1
SCHEMBL24011046 0.81 MAPT (0.49) MAPTGAAALDH1A1KDM4EMEN1
SCHEMBL6576141 0.80 MAPT (0.95) MAPTGAAALDH1A1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4855308-A Method of treating senile cognitive decline with N'-substituted aminopyridine adrenergic agents WARNER-LAMBERT COMPANY (US) 1989-08-08 — — US claimed
US-20250275463-A1 TETRADENTATE PLATINUM COMPLEX LIGHT-EMITTING MATERIAL BASED ON TETRAARYLETHYLENE SKELETON STRUCTURE AND USE THEREOF GUANGDONG AGLAIA OPTOELECTRONIC MATERIALS CO., LTD (CN) 2025-08-28 — — US disclosed
WO-2023207622-A1 TETRADENTATE PLATINUM COMPLEX LUMINESCENT MATERIAL BASED ON TETRAARYLETHYLENE SKELETON STRUCTURE AND USE THEREOF 广东阿格蕾雅光电材料有限公司 2023-11-02 — — WO disclosed
CN-116396335-A Tetradentate platinum complex luminescent material based on tetraarylethylene skeleton structure and application thereof 广东阿格蕾雅光电材料有限公司 2023-07-07 — — CN disclosed
CN-111747933-B Substituted 1,3, 5-triazine compound, composition and application thereof 吉林省元合电子材料有限公司 2022-03-01 — — CN disclosed
CN-111747937-B 1,3, 5-triazine compound, composition and application thereof 吉林省元合电子材料有限公司 2022-01-14 — — CN disclosed
CN-111747936-B Substituted 1,3, 5-triazine compound, composition and application thereof 吉林省元合电子材料有限公司 2021-10-22 — — CN disclosed
CN-111747936-A Substituted 1,3, 5-triazine compound, composition and application thereof 吉林省元合电子材料有限公司 2020-10-09 — — CN disclosed
CN-111747937-A 1,3, 5-triazine compound, composition and application thereof 吉林省元合电子材料有限公司 2020-10-09 — — CN disclosed
CN-111747933-A Substituted 1,3, 5-triazine compound, composition and application thereof 吉林省元合电子材料有限公司 2020-10-09 — — CN disclosed
CN-102076813-A organic electroluminescent device MERCK PATENT GMBH 2011-05-25 — — CN disclosed
JP-2008156247-A METHOD FOR PURIFYING 4-(2-AMINOANILINO)PYRIDINE KOEI CHEM CO LTD 2008-07-10 — — JP disclosed
JP-2008156247-A METHOD FOR PURIFYING 4-(2-AMINOANILINO)PYRIDINE KOEI CHEM CO LTD 2008-07-10 — — JP disclosed
US-20040181062-A1 Benzimidazole cyclooxygenase-2 inhibitor PFIZER INC 2004-09-16 — — US disclosed
US-6713482-B2 SUCH AS (E)-1-(2-PYRIDYL)-2-STYRYL-1H-BENZIMIDAZOLE; ANTIINFLAMMATORY AND ANALGESIC AGENTS; PROSTAGLANDIN INHIBITORS PFIZER INC. 2004-03-30 — — US disclosed
US-20030013886-A1 Benzimidazole cyclooxygenase-2 inhibitors OKUMURA YOSHIYUKI (JP) 2003-01-16 — — US disclosed
EP-0937722-B1 Benzimidazole derivatives as cyclooxygenase-2 inhibitors PFIZER (US) 2002-07-03 — — EP disclosed
US-6310079-B1 NON-STEROIDAL ANTIINFLAMMATORY AGENTS PFIZER INC. 2001-10-30 — — US disclosed
EP-0937722-A1 Benzimidazole derivatives as cyclooxygenase-2 inhibitors PFIZER INC. (US) 1999-08-25 — — EP disclosed
US-4855308-A Method of treating senile cognitive decline with N'-substituted aminopyridine adrenergic agents WARNER-LAMBERT COMPANY (US) 1989-08-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250275463-A1 TETRADENTATE PLATINUM COMPLEX LIGHT-EMITTING MATERIAL BASED ON TETRAARYLETHYLENE SKELETON STRUCTURE AND USE THEREOF TTI2, TTI1, LAGE3 MAPT 304/4885GAA 3865/4885ALDH1A1 1959/4885
US-20030013886-A1 Benzimidazole cyclooxygenase-2 inhibitors PTGS1, CBR1, CBR3 MAPT 4772/4885GAA 4601/4885ALDH1A1 209/4885
US-20040181062-A1 Benzimidazole cyclooxygenase-2 inhibitor PTGS1, CBR1, CBR3 MAPT 4736/4885GAA 4624/4885ALDH1A1 203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.